Harvard Bioscience, Inc. (HBIO)

NCM – Real Time Price. Currency in USD

6.22

+0.09 (1.49%)

Market open: Aug 12, 2026, 11:38 AM EDT

6.06

-0.07 (-1.14%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

87M

94M

112M

113M

Cost of goods sold

-41M

-45M

-51M

-57M

Gross Profit

46M

50M

61M

56M

Operating expenses (excl. COGS)

-46M

-54M

-59M

-61M

Operating Income

100K

-5M

Non-operating income, total

-57M

-7M

-5M

-4M

Pretax income

-57M

-12M

-3M

-9M

Equity in earnings

Taxes

686K

-740K

-859K

-337K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-57M

-12M

-3M

-10M

Discontinued operations

Net income

-57M

-12M

-3M

-10M

Dilution adjustment

Preferred dividends

Harvard Bioscience, Inc. (HBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Harvard Bioscience, Inc. (HBIO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Harvard Bioscience, Inc. (HBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Harvard Bioscience, Inc. (HBIO)

Income Statement (Annual)

Income Statement (Annual)